{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:43:17Z","timestamp":1791830597383,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This systematic review sought to understand the types of quality of life or clinical outcome measures currently being utilised for autoimmune encephalitis (AE) patients to determine whether the current measured outcomes accurately represented the full disease burden of AE. This included how the measures were being used (e.g., time point utilised, as an endpoint or as a categorisation method), and what the recorded measures were. The review included all studies that fulfilled the population criteria, which included probable AE. A search conducted on the 24th of June 2024 on PubMed and Embase returned 302 studies that fulfilled the inclusion criteria. Of the 302, the most commonly used measures were the Modified Rankin Scale (mRS) being utilised in 90.07% of studies, followed by Clinical Assessment Scale in Autoimmune Encephalitis (CASE) at 15.56%, Montreal Cognitive Assessment (MoCA) at 7.95%, and finally Mini Mental State Examination (MMSE) at 4.97%. The most common phenotype in the literature was NMDA AE, with 208 studies (68.87%) investigating this cohort. There was significant heterogeneity in the application of measures, such as definitional differences (e.g., a good outcome defined as an mRS of &lt;\u20091 for some papers, but &lt;\u20092 for others), utilising measures at differing time points within the disease course of an individual, and the inconsistent reporting of key information, such as comorbidities that may impact the measures being used. This review found the current clinical measures do not holistically encompass the disease burden of AE,\n                    <jats:italic>with current clinical measures experiencing deficiencies in capturing the effect of AE on sleep and psychosocial function<\/jats:italic>\n                    . It is recommended that future studies utilise symptom onset as a standardised time metric, and either a combination of currently available measures, or the creation or validation of new methods to capture disease burden in AE patients.\n                  <\/jats:p>","DOI":"10.1186\/s13023-025-03837-7","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:35:26Z","timestamp":1749810926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigating health related quality of life and clinical measures in autoimmune encephalitis: a systematic review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4560-3320","authenticated-orcid":false,"given":"Leonard","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovi","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan Min-Wei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"8","key":"3837_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3949\/ccjm.88a.20122","volume":"88","author":"JR Abbatemarco","year":"2021","unstructured":"Abbatemarco JR, Yan C, Kunchok A, Rae-Grant A. Antibody-mediated autoimmune encephalitis: A practical approach. Cleve Clin J Med. 2021;88(8):459\u201371.","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"3837_CR2","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","volume":"7","author":"T Cellucci","year":"2020","unstructured":"Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflammation. 2020;7(2):e663.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"4","key":"3837_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"9","key":"3837_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/brainsci12091130","volume":"12","author":"A Patel","year":"2022","unstructured":"Patel A, Meng Y, Najjar A, Lado F, Najjar S. Autoimmune encephalitis: A physician\u2019s guide to the clinical spectrum diagnosis and management. Brain Sci. 2022;12(9):1130.","journal-title":"Brain Sci"},{"issue":"8","key":"3837_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114\u201328.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3837_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/imj.12749","volume":"45","author":"PN Britton","year":"2015","unstructured":"Britton PN, Eastwood K, Paterson B, Durrheim DN, Dale RC, Cheng AC, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and new Zealand. Intern Med J. 2015;45(5):563\u201376.","journal-title":"Intern Med J"},{"issue":"7","key":"3837_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757\u201368.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"3837_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. Am J Neuroradiol. 2017;38(6):1070\u20138.","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"3837_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377.","journal-title":"Ann Neurol"},{"issue":"4","key":"3837_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon T, Michael BD, Smith PE, Sanderson F, Davies NWS, Hart IJ, et al. Management of suspected viral encephalitis in adults\u2013 association of British neurologists and British infection association National guidelines. J Infect. 2012;64(4):347\u201373.","journal-title":"J Infect"},{"issue":"2","key":"3837_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365.","journal-title":"Lancet Neurol"},{"issue":"18","key":"3837_CR12","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus. Neurology. 2015;85(18):1604\u201313.","journal-title":"Neurology"},{"key":"3837_CR13","doi-asserted-by":"publisher","unstructured":"Herken J, Pr\u00fcss H. Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Front Psychiatry [Internet]. 2017 Feb 16 [cited 2025 Jan 16];8. Available from: https:\/\/www.frontiersin.org\/journals\/psychiatry\/articles\/https:\/\/doi.org\/10.3389\/fpsyt.2017.00025\/full","DOI":"10.3389\/fpsyt.2017.00025\/full"},{"issue":"5","key":"3837_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","volume":"69","author":"AML Quek","year":"2012","unstructured":"Quek AML, Britton JW, McKeon A, So E, Lennon VA, Shin C, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69(5):582\u201393.","journal-title":"Arch Neurol"},{"key":"3837_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0038-1660819","volume":"38","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Flanagan EP. Diagnostic and therapeutic approach to autoimmune neurologic disorders. Semin Neurol. 2018;38:392\u2013402.","journal-title":"Semin Neurol"},{"issue":"5","key":"3837_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1017\/cjn.2018.33","volume":"45","author":"J H\u00e9bert","year":"2018","unstructured":"H\u00e9bert J, Day GS, Steriade C, Wennberg RA, Tang-Wai DF. Long-Term cognitive outcomes in patients with autoimmune encephalitis. Can J Neurol Sci. 2018;45(5):540\u20134.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"3837_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1212\/CON.0000000000000299","volume":"22","author":"A McKeon","year":"2016","unstructured":"McKeon A. Autoimmune encephalopathies and dementias. Contin Lifelong Learn Neurol. 2016;22(2):538.","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"1","key":"3837_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol Seoul Korea. 2016;12(1):1\u201313.","journal-title":"J Clin Neurol Seoul Korea"},{"issue":"9","key":"3837_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F, Antibody-Mediated, Encephalitis. N Engl J Med. 2018;378(9):840\u201351.","journal-title":"N Engl J Med"},{"key":"3837_CR20","doi-asserted-by":"publisher","unstructured":"Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother [Internet]. 2015 Dec 2 [cited 2025 Jan 16]; Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.1586\/14737175.2015.1115720","DOI":"10.1586\/14737175.2015.1115720"},{"issue":"2","key":"3837_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1352458515581438","volume":"22","author":"H Abboud","year":"2016","unstructured":"Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler J. 2016;22(2):185\u201392.","journal-title":"Mult Scler J"},{"issue":"3","key":"3837_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s13311-021-01178-4","volume":"19","author":"I Smets","year":"2022","unstructured":"Smets I, Titulaer MJ. Antibody therapies in autoimmune encephalitis. Neurotherapeutics. 2022;19(3):823\u201331.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"3837_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","volume":"21","author":"CE Uy","year":"2021","unstructured":"Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol. 2021;21(5):412\u201323.","journal-title":"Pract Neurol"},{"issue":"1","key":"3837_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12883-018-1099-z","volume":"18","author":"W Li","year":"2018","unstructured":"Li W, Wu S, Meng Q, Zhang X, Guo Y, Cong L, et al. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol. 2018;18(1):96.","journal-title":"BMC Neurol"},{"key":"3837_CR25","doi-asserted-by":"publisher","first-page":"175628561772234","DOI":"10.1177\/1756285617722347","volume":"11","author":"YW Shin","year":"2018","unstructured":"Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2018;11:1756285617722347.","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"3837_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/ene.13324","volume":"24","author":"M Celicanin","year":"2017","unstructured":"Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, et al. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies\u2013 a National cohort study. Eur J Neurol. 2017;24(8):999\u20131005.","journal-title":"Eur J Neurol"},{"issue":"3","key":"3837_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","volume":"27","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol. 2014;27(3):361\u20138.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"3837_CR28","doi-asserted-by":"publisher","first-page":"e200306","DOI":"10.1212\/CPJ.0000000000200306","volume":"14","author":"AZ Mahadeen","year":"2024","unstructured":"Mahadeen AZ, Carlson AK, Cohen JA, Galioto R, Abbatemarco JR, Kunchok A. Review of the longitudinal management of autoimmune encephalitis, potential biomarkers, and novel therapeutics. Neurol Clin Pract. 2024;14(4):e200306.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"3837_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4103\/aian.AIAN_817_20","volume":"24","author":"AK Datta","year":"2021","unstructured":"Datta AK, Pandit A, Biswas S, Biswas A, Roy BK, Gangopaddhyay G. Spectrum of anti-NMDA receptor antibody encephalitis: clinical profile, management and outcomes. Ann Indian Acad Neurol. 2021;24(3):383\u20139.","journal-title":"Ann Indian Acad Neurol"},{"key":"3837_CR30","doi-asserted-by":"publisher","unstructured":"Kang Q, Liao H, Yang L, Fang H, Hu W, Wu L. Clinical Characteristics and Short-Term Prognosis of Children With Antibody-Mediated Autoimmune Encephalitis: A Single-Center Cohort Study. Front Pediatr [Internet]. 2022 Jul 8 [cited 2025 Jan 18];10. Available from: https:\/\/www.frontiersin.org\/journals\/pediatrics\/articles\/https:\/\/doi.org\/10.3389\/fped.2022.880693\/full","DOI":"10.3389\/fped.2022.880693\/full"},{"key":"3837_CR31","doi-asserted-by":"publisher","unstructured":"Zhang Y, Tu E, Yao C, Liu J, Lei Q, Lu W. Validation of the Clinical Assessment Scale in Autoimmune Encephalitis in Chinese Patients. Front Immunol [Internet]. 2021 Dec 17 [cited 2024 Jul 19];12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.796965\/full","DOI":"10.3389\/fimmu.2021.796965\/full"},{"issue":"6","key":"3837_CR32","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1212\/NXI.0000000000001064","volume":"8","author":"LA Diaz-Arias","year":"2021","unstructured":"Diaz-Arias LA, Yeshokumar AK, Glassberg B, Sumowski JF, Easton A, Probasco JC, et al. Fatigue in survivors of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflammation. 2021;8(6):e1064.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3837_CR33","doi-asserted-by":"publisher","unstructured":"Madani J, Yea C, Mahjoub A, Brna P, Jones K, Longoni G et al. Clinical features and outcomes in children with seronegative autoimmune encephalitis. Dev Med Child Neurol [Internet]. [cited 2024 Jul 21];n\/a(n\/a). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1111\/dmcn.15896","DOI":"10.1111\/dmcn.15896"},{"issue":"1","key":"3837_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-022-02622-8","volume":"19","author":"Y Du","year":"2022","unstructured":"Du Y, Zhao C, Liu J, Li C, Yan Q, Li L, et al. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. J Neuroinflammation. 2022;19(1):259.","journal-title":"J Neuroinflammation"},{"issue":"15supplement","key":"3837_CR35","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1212\/WNL.96.15_supplement.2482","volume":"96","author":"Y Jang","year":"2021","unstructured":"Jang Y, Lee WJ, Lee HS, Chu K, Lee SK, Lee ST. Tofacitinib treatment in refractory autoimmune encephalitis (2482). Neurology. 2021;96(15supplement):2482.","journal-title":"Neurology"},{"issue":"10","key":"3837_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S1474-4422(22)00299-X","volume":"21","author":"M Guasp","year":"2022","unstructured":"Guasp M, Rosa-Justicia M, Mu\u00f1oz-Lopetegi A, Mart\u00ednez-Hern\u00e1ndez E, Armangu\u00e9 T, Sugranyes G, et al. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders. Lancet Neurol. 2022;21(10):899\u2013910.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3837_CR37","doi-asserted-by":"publisher","first-page":"e200115","DOI":"10.1212\/NXI.0000000000200115","volume":"10","author":"S Alkabie","year":"2023","unstructured":"Alkabie S, Budhram A. Prolonged corticosteroids without maintenance immunotherapy for treatment of Anti-LGI1 encephalitis. Neurol Neuroimmunol Neuroinflammation. 2023;10(3):e200115.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"4","key":"3837_CR38","doi-asserted-by":"publisher","first-page":"e208019","DOI":"10.1212\/WNL.0000000000208019","volume":"102","author":"A Morgan","year":"2024","unstructured":"Morgan A, Li Y, Thompson NR, Milinovich A, Abbatemarco JR, Cohen JA, et al. Longitudinal disability, cognitive impairment, and mood symptoms in patients with Anti-NMDA receptor encephalitis. Neurology. 2024;102(4):e208019.","journal-title":"Neurology"},{"issue":"1","key":"3837_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10072-023-06968-6","volume":"45","author":"M Liu","year":"2024","unstructured":"Liu M, Xu X, Fan S, Ren H, Zhao Y, Guan H. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma\u2013inactivated protein 1 encephalitis: a prospective observational cohort study. Neurol Sci. 2024;45(1):253\u201360.","journal-title":"Neurol Sci"},{"issue":"2","key":"3837_CR40","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1212\/NXI.0000000000000652","volume":"7","author":"N Sola-Valls","year":"2020","unstructured":"Sola-Valls N, Ari\u00f1o H, Escudero D, Solana E, Llad\u00f3 A, S\u00e1nchez-Valle R, et al. Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis. Neurol Neuroimmunol Neuroinflammation. 2020;7(2):e652.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3837_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2017.03.020","volume":"376","author":"M Szots","year":"2017","unstructured":"Szots M, Blaabjerg M, Orsi G, Iversen P, Kondziella D, Madsen CG, et al. Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study. J Neurol Sci. 2017;376:159\u201365.","journal-title":"J Neurol Sci"},{"key":"3837_CR42","doi-asserted-by":"publisher","unstructured":"Li C, Pang X, Shi K, Long Q, Liu J, Zheng J. The Insula Is a Hub for Functional Brain Network in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Front Neurosci [Internet]. 2021 Mar 15 [cited 2024 Jul 19];15. Available from: https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/https:\/\/doi.org\/10.3389\/fnins.2021.642390\/full","DOI":"10.3389\/fnins.2021.642390\/full"},{"issue":"5","key":"3837_CR43","doi-asserted-by":"publisher","first-page":"e200013","DOI":"10.1212\/NXI.0000000000200013","volume":"9","author":"A Yeshokumar","year":"2022","unstructured":"Yeshokumar A, Gordon-Lipkin E, Arenivas A, Rosenfeld M, Patterson K, Blum R, et al. Younger age at onset is associated with worse Long-term behavioral outcomes in Anti-NMDA receptor encephalitis. Neurol Neuroimmunol Neuroinflammation. 2022;9(5):e200013.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"10","key":"3837_CR44","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1161\/STROKEAHA.109.557256","volume":"40","author":"TJ Quinn","year":"2009","unstructured":"Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin scale. Stroke. 2009;40(10):3393\u20135.","journal-title":"Stroke"},{"issue":"3","key":"3837_CR45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1161\/STROKEAHA.108.522516","volume":"40","author":"TJ Quinn","year":"2009","unstructured":"Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the reliability of the modified Rankin scale. Stroke. 2009;40(3):762\u20136.","journal-title":"Stroke"},{"issue":"11","key":"3837_CR46","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","volume":"78","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Eyre M, Molteni E, Thomas T, Irani SR, Dalmau J, et al. Use and safety of immunotherapeutic management of N-Methyl-d-Aspartate receptor antibody encephalitis: A Meta-analysis. JAMA Neurol. 2021;78(11):1333\u201344.","journal-title":"JAMA Neurol"},{"issue":"7","key":"3837_CR47","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10072-024-07382-2","volume":"45","author":"SP Griffith","year":"2024","unstructured":"Griffith SP, Wesselingh R, D\u2019Aprano F, Seery N, Rushen T, Kyndt C, et al. Language impairments in seropositive and seronegative autoimmune encephalitis. Neurol Sci. 2024;45(7):3389\u201398.","journal-title":"Neurol Sci"},{"issue":"1","key":"3837_CR48","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00415-023-11967-w","volume":"271","author":"SP Griffith","year":"2024","unstructured":"Griffith SP, Wesselingh R, Seery N, Rushen T, Kyndt C, Long B, et al. Characterizing cognitive function in patients with autoimmune encephalitis: an Australian prospective study. J Neurol. 2024;271(1):310\u201324.","journal-title":"J Neurol"},{"key":"3837_CR49","first-page":"73","volume":"58","author":"Y Urakami","year":"2016","unstructured":"Urakami Y. Neurocognitive rehabilitation following anti-NMDA-receptor encephalitis. Act Nerv Super Rediviva. 2016;58:73.","journal-title":"Act Nerv Super Rediviva"},{"issue":"5","key":"3837_CR50","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/dmcn.15429","volume":"65","author":"L Flet-Berliac","year":"2023","unstructured":"Flet-Berliac L, Tchitchek N, L\u00e9pine A, Florea A, Maurey H, Chr\u00e9tien P, et al. Long\u2010term outcome of paediatric anti\u2010N\u2010methyl\u2010D\u2010aspartate receptor encephalitis. Dev Med Child Neurol. 2023;65(5):691\u2013700.","journal-title":"Dev Med Child Neurol"},{"key":"3837_CR51","unstructured":"Binks S, Veldsman M, Jacob S, Maddison P, Coebergh J, Michael S et al. Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing. Eur J Neurol. 2020;27(Supplement 1)."},{"issue":"3","key":"3837_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"J Lim","year":"2019","unstructured":"Lim J, Lee S, Moon J, Jun J, Kim T, Shin Y, et al. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol. 2019;85(3):352\u20138.","journal-title":"Ann Neurol"},{"key":"3837_CR53","doi-asserted-by":"publisher","first-page":"120124","DOI":"10.1016\/j.jns.2021.120124","volume":"434","author":"H Abboud","year":"2022","unstructured":"Abboud H, Briggs F, Buerki R, Elkasaby M, BacaVaca GF, Fotedar N, et al. Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults. J Neurol Sci. 2022;434:120124.","journal-title":"J Neurol Sci"},{"issue":"1","key":"3837_CR54","doi-asserted-by":"publisher","first-page":"e200178","DOI":"10.1212\/NXI.0000000000200178","volume":"11","author":"A Aboseif","year":"2024","unstructured":"Aboseif A, Li Y, Amin M, Lapin B, Milinovich A, Abbatemarco JR, et al. Clinical determinants of longitudinal disability in LGI-1-IgG autoimmune encephalitis. Neurol Neuroimmunol Neuroinflammation. 2024;11(1):e200178.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"2","key":"3837_CR55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40120-021-00278-9","volume":"10","author":"MT Cai","year":"2021","unstructured":"Cai MT, Lai QL, Zheng Y, Fang GL, Qiao S, Shen CH, et al. Validation of the clinical assessment scale for autoimmune encephalitis: A multicenter study. Neurol Ther. 2021;10(2):985\u20131000.","journal-title":"Neurol Ther"},{"key":"3837_CR56","doi-asserted-by":"publisher","unstructured":"Soellradl E, von Oertzen TJ, Wagner JN. Evaluation of the clinical assessment scale for autoimmune encephalitis (CASE) in a retrospective cohort and a systematic review. Neurol Sci [Internet]. 2024 Jun 11 [cited 2024 Jul 19]; Available from: https:\/\/doi.org\/10.1007\/s10072-024-07642-1","DOI":"10.1007\/s10072-024-07642-1"},{"issue":"1","key":"3837_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47936\/encephalitis.2022.00073","volume":"3","author":"DL Koo","year":"2023","unstructured":"Koo DL. Sleep disturbances in autoimmune encephalitis. Encephalitis. 2023;3(1):1\u20136.","journal-title":"Encephalitis"},{"issue":"12","key":"3837_CR58","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S1474-4422(20)30341-0","volume":"19","author":"A Mu\u00f1oz-Lopetegi","year":"2020","unstructured":"Mu\u00f1oz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020;19(12):1010\u201322.","journal-title":"Lancet Neurol"},{"issue":"40","key":"3837_CR59","doi-asserted-by":"publisher","first-page":"e35162","DOI":"10.1097\/MD.0000000000035162","volume":"102","author":"Y Yokota","year":"2023","unstructured":"Yokota Y, Hirose S, Hara M, Nakajima H. Long-term outcomes and health-related quality of life in patients with autoimmune encephalitis: an observational study. Med (Baltim). 2023;102(40):e35162.","journal-title":"Med (Baltim)"},{"issue":"10","key":"3837_CR60","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/acn3.51865","volume":"10","author":"S Macher","year":"2023","unstructured":"Macher S, Bsteh G, H\u00f6ftberger R, Berger T, Rommer P, Zrzavy T. Clinical scales in autoimmune encephalitis\u2014A retrospective monocentric cohort study. Ann Clin Transl Neurol. 2023;10(10):1768\u201375.","journal-title":"Ann Clin Transl Neurol"},{"key":"3837_CR61","doi-asserted-by":"publisher","unstructured":"Liu X, Yu T, Zhao X, Yu P, Lv R, Wang C et al. Risk Factors and Brain Metabolic Mechanism of Sleep Disorders in Autoimmune Encephalitis. Front Immunol [Internet]. 2021 Nov 24 [cited 2024 Jul 19];12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.738097\/full","DOI":"10.3389\/fimmu.2021.738097\/full"},{"issue":"1","key":"3837_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12888-022-04505-x","volume":"23","author":"H Wu","year":"2023","unstructured":"Wu H, Wu C, Zhou Y, Huang S, Zhu S. Catatonia in adult anti-NMDAR encephalitis: an observational cohort study. BMC Psychiatry. 2023;23(1):94.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"3837_CR63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/NRE-141176","volume":"35","author":"LJ Bach","year":"2014","unstructured":"Bach LJ. Long term rehabilitation management and outcome of anti-NMDA receptor encephalitis: case reports. NeuroRehabilitation. 2014;35(4):863\u201375.","journal-title":"NeuroRehabilitation"},{"issue":"1","key":"3837_CR64","doi-asserted-by":"publisher","first-page":"e200041","DOI":"10.1212\/NXI.0000000000200041","volume":"10","author":"J Benoit","year":"2022","unstructured":"Benoit J, Mu\u00f1iz-Castrillo S, Vogrig A, Farina A, Pinto AL, Picard G, et al. Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis. Neurol Neuroimmunol Neuroinflammation. 2022;10(1):e200041.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3837_CR65","doi-asserted-by":"crossref","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med [Internet]. 2016 Oct 4 [cited 2024 Jul 21]; Available from: https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2050312116671725","DOI":"10.1177\/2050312116671725"},{"issue":"23","key":"3837_CR66","first-page":"1860","volume":"78","author":"D Cella","year":"2012","unstructured":"Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, et al. Neuro-QOL Neurol. 2012;78(23):1860\u20137.","journal-title":"Neuro-QOL Neurol"},{"issue":"22","key":"3837_CR67","doi-asserted-by":"publisher","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Petit Pedrol M, Maudes E, Simabukuro M, Mu\u00f1iz-Castrillo S, Pinto AL, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. 2020;95(22):e3012\u201325.","journal-title":"Neurology"},{"key":"3837_CR68","doi-asserted-by":"publisher","unstructured":"Zhou H, Deng Q, Yang Z, Tai Z, Liu K, Ping Y et al. Performance of the clinical assessment scale for autoimmune encephalitis in a pediatric autoimmune encephalitis cohort. Front Immunol [Internet]. 2022 Oct 14 [cited 2024 Jul 19];13. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2022.915352\/full","DOI":"10.3389\/fimmu.2022.915352\/full"},{"issue":"1","key":"3837_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.braindev.2022.09.009","volume":"45","author":"PK Panda","year":"2023","unstructured":"Panda PK, Sharawat IK, Ramachandran A, Elwadhi A, Tomar A, Bhardwaj S, et al. Validity and prognostic utility of clinical assessment scale for autoimmune encephalitis (CASE) score in children with autoimmune encephalitis. Brain Dev. 2023;45(1):8\u201315.","journal-title":"Brain Dev"},{"issue":"3","key":"3837_CR70","doi-asserted-by":"publisher","first-page":"e200102","DOI":"10.1212\/NXI.0000000000200102","volume":"10","author":"M Nikolaus","year":"2023","unstructured":"Nikolaus M, Rausch P, Rost\u00e1sy K, Bertolini A, Wickstr\u00f6m R, Johannsen J, et al. Retrospective pediatric cohort study validates NEOS score and demonstrates applicability in children with Anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflammation. 2023;10(3):e200102.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"3","key":"3837_CR71","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","volume":"92","author":"R Balu","year":"2019","unstructured":"Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):e244\u201352.","journal-title":"Neurology"},{"issue":"6","key":"3837_CR72","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s10072-021-05838-3","volume":"43","author":"X Ma","year":"2022","unstructured":"Ma X, Lu Y, Peng F, Wang Y, Sun X, Luo W, et al. Serum NfL associated with anti-NMDA receptor encephalitis. Neurol Sci. 2022;43(6):3893\u20139.","journal-title":"Neurol Sci"},{"issue":"4","key":"3837_CR73","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/acn3.52006","volume":"11","author":"SNM Binks","year":"2024","unstructured":"Binks SNM, Veldsman M, Handel AE, Jacob S, Maddison P, Coebergh J, et al. Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis. Ann Clin Transl Neurol. 2024;11(4):1053\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"3837_CR74","doi-asserted-by":"publisher","first-page":"107066","DOI":"10.1016\/j.yebeh.2020.107066","volume":"108","author":"AR Tomlinson","year":"2020","unstructured":"Tomlinson AR, Blum RA, Jett\u00e9 N, Kwon CS, Easton A, Yeshokumar AK. Assessment of care transitions and caregiver burden in anti-NMDA receptor encephalitis. Epilepsy Behav. 2020;108:107066.","journal-title":"Epilepsy Behav"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03837-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03837-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03837-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:44Z","timestamp":1781604584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-03837-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3837"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03837-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\u2013 systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2013 systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}